Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,970
Closed -$391K 851
2025
Q2
$391K Buy
3,970
+252
+7% +$23.8K 0.04% 489
2025
Q1
$344K Sell
3,718
-687
-16% -$63.3K 0.04% 481
2024
Q4
$400K Buy
4,405
+155
+4% +$14.2K 0.04% 639
2024
Q3
$410K Buy
4,250
+428
+11% +$41.8K 0.04% 700
2024
Q2
$351K Sell
3,822
-52
-1% -$4.83K 0.04% 624
2024
Q1
$357K Sell
3,874
-193
-5% -$18.1K 0.04% 698
2023
Q4
$387K Buy
4,067
+780
+24% +$72.9K 0.04% 444
2023
Q3
$307K Sell
3,287
-155
-5% -$14.3K 0.04% 548
2023
Q2
$315K Sell
3,442
-248
-7% -$20.3K 0.04% 516
2023
Q1
$271K Buy
3,690
+871
+31% +$75.4K 0.03% 732
2022
Q4
$235K Buy
2,819
+710
+34% +$64K 0.03% 556
2022
Q3
$204K Buy
2,109
+105
+5% +$12.5K 0.03% 721
2022
Q2
$211K Buy
2,004
+637
+47% +$81.4K 0.03% 628
2022
Q1
$236K Sell
1,367
-124
-8% -$18.5K 0.03% 467
2021
Q4
$241K Sell
1,491
-19
-1% -$3.05K 0.03% 769
2021
Q3
$225K Buy
+1,510
New +$314K 0.03% 695
2021
Q1
Sell
-1,656
Closed -$485K 602
2020
Q4
$485K Buy
+1,656
New +$425K 0.11% 173
2018
Q1
Sell
-1,056
Closed -$56K 217
2017
Q4
$56K Buy
+1,056
New +$55.7K 0.05% 523

Other funds holding AMED

Inspire Investing's AMED Position: Q3 2025 in Review

Inspire Investing sold out of Amedisys (AMED) in Q3 2025, closing a stake of 3,970 shares — an estimated $391K sold.

Inspire Investing first reported a position in AMED in Q4 2017 and held it in 18 quarters. The position peaked at $485K in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Inspire Investing reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Inspire Investing sold 3,970 Amedisys shares in Q3 2025, an estimated $391K.
  • Inspire Investing first reported a position in Amedisys in Q4 2017 and held it in 18 quarters.
  • Inspire Investing's Amedisys position peaked at $485K in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Inspire Investing's 13F filing for Q3 2025, filed 15 Oct 2025.